ENDUREA
Finding published by the FDA
Finding published by the FDA
Finding date: 2 January 2024.
Undeclared tadalafil and sildenafil
- FDA finding date
- 2 January 2024
- Company
- name not reproduced (no recognised company form)
- Subject published by the FDA
- Undeclared tadalafil and sildenafil
- Published action
- Public Notification
- Programme
- Drugs
This official finding is dated and does not necessarily describe the product currently sold under this name. It does not constitute an analysis of its complete composition.
The subject and action are reproduced as published by the FDA, without generalisation to all batches or other products from the company.
Substances named in the FDA finding
| Published name | Published text and quantity | Recognised ingredient | Role or context |
|---|---|---|---|
| tadalafil | Undeclared tadalafil and sildenafil | Not recognised | Substance named by the FDA |
| sildenafil | Undeclared tadalafil and sildenafil | Not recognised | Substance named by the FDA |
Substances named in the FDA finding do not constitute a complete composition. No quantity or dose is inferred.
Sites cited by the FDA
amazon.com
Official source
Food and Drug Administration, Health Fraud Product Database. Constats officiels datés.